Business
Which biotech’s shares have hit a 12-month high on good news from the FDA?
Image source: Getty Images
Shareholders in Neuren Pharmaceuticals Ltd (ASX: NEU) are rejoicing after one of the company’s drugs, which shows promise in treating a rare genetic disorder, received fast-track designation from the US Food & Drug Administration (FDA).
Neuren told the ASX in a…
Continue Reading
-
Noosa News22 hours agoBondi Beach terror attack: Police investigate threat against Westfield North Lakes in Queensland
-
Noosa News23 hours agoBrand update as firm marks 25 years – Proctor
-
General23 hours agoSea search for missing Victorian man off Cape Jaffa ends
-
Noosa News23 hours agoLucky few Zone RV customers rejoice after receiving caravans from collapsed manufacturer